Medtronic | MDT - Selling And Administration Expenses

Stock Price
76.12
Daily Change
-0.75 -0.98%
Monthly
-11.12%
Yearly
-11.92%
Q2 Forecast
73.77

Medtronic reported 2.97B in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
AtriCure USD 84.55M 6.21M Mar/2026
Baxter International USD 728M 33M Mar/2026
Becton, Dickinson and Co. USD 1.21B 180M Mar/2026
Boston Scientific USD 1.78B 53M Mar/2026
Cooper Companies USD 373.1M 46.1M Dec/2025
Danaher USD 1.86B 166M Mar/2026
Dexcom USD 349.7M 49.8M Mar/2026
Edwards Lifesciences USD 522.2M 80.7M Mar/2026
Globus Medical USD 297.77M 20.7M Mar/2026
Inogen USD 43.77M 510K Jun/2024
Insulet USD 317.2M 14.2M Mar/2026
Integra LifeSciences USD 178.24M 21.79M Mar/2026
Intuitive Surgical USD 613.3M 73.8M Mar/2026
J&J USD 6.03B 719M Mar/2026
Masimo USD 143.4M 15.4M Mar/2026
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 110.47M 4.36M Mar/2026
Philips EUR 1.18B 121M Mar/2026
Smith & Nephew USD 1.42B 65M Dec/2025
Stryker USD 2.15B 17M Mar/2026
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 226.01M 3.64M Mar/2026
Terumo JPY 105.26B 7.38B Dec/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Zimmer Biomet Holdings USD 849.9M 5.8M Mar/2026